JC: is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Is Persistent Functional deficit following Mild Traumatic Brain Injury more common than we thought?
Head Injury
JC: Early plasma use in traumatic brain injury. St Emlyn’s
There seems to be a lot of really interesting papers on Traumatic Brain Injury (TBI) this year. A welcome relief from COVID 19 perhaps but also a reminder that other
JC: Early plasma use in traumatic brain injury. St Emlyn’s Read More
JC: TXA in severe head injury. St Emlyn’s
Our post on the CRASH-3 trial, an RCT examining the use of TXA in head injury, was arguably our most controversial of 2019 (1). Our view was that the evidence
JC: TXA in severe head injury. St Emlyn’s Read More
Tranexamic Acid (TXA) in Head Injury: CRASH-3 results
A review of the CRASH-3 trial and whether tranexamic acid (TXA) is of benefit in traumatic brain injury patients.
Tranexamic Acid (TXA) in Head Injury: CRASH-3 results Read More
#RCEMasc 2019 Day 1: St Emlyn’s goes north!
We’re at the RCEM scientific conference 2019, and here are the key lessons we learnt on day 1!
#RCEMasc 2019 Day 1: St Emlyn’s goes north! Read More
Podcast – March 2019 Monthly Round Up
Here’s our regular monthly round up of the best of the blog from March 2019
Podcast – March 2019 Monthly Round Up Read More
Top 10 trauma papers 2018-2019 for TraumaUK conference. St Emlyn’s
I’m back in the Midlands at the excellent and great value TraumaUK conference. If you’ve not been to this conference then I’d strongly suggest you do next year. It’s an
Top 10 trauma papers 2018-2019 for TraumaUK conference. St Emlyn’s Read More
Trauma in the UK, who cares?
We care about trauma. All of us are practising clinicians in healthcare and all of us see trauma in our clinical jobs. Some of my most memorable cases are the
Trauma in the UK, who cares? Read More